17β-Estradiol Promotes Breast Cancer Cell Proliferation-Inducing Stromal Cell-Derived Factor-1-Mediated Epidermal Growth Factor Receptor Transactivation: Reversal by Gefitinib Pretreatment-Reference-Cited by-同舟云学术

17β-Estradiol Promotes Breast Cancer Cell Proliferation-Inducing Stromal Cell-Derived Factor-1-Mediated Epidermal Growth Factor Receptor Transactivation: Reversal by Gefitinib Pretreatment

Published:2007-10-24 Issue:1 Volume:73 Page:191-202
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Pattarozzi Alessandra,Gatti Monica,Barbieri Federica,Würth Roberto,Porcile Carola,Lunardi Gianluigi,Ratto Alessandra,Favoni Roberto,Bajetto Adriana,Ferrari Angelo,Florio Tullio

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference42 articles.

1. An Intracellular Multi-Effector Complex Mediates Somatostatin Receptor 1 Activation of Phospho-Tyrosine Phosphatase η

2. CXCR4 and SDF1 expression in human meningiomas: A proliferative role in tumoral meningothelial cells in vitro1

3. The significance of cancer cell expression of the chemokine receptor CXCR4

4. Chemokines and their receptors in the CNS: expression of CXCL12/SDF-1 and CXCR4 and their role in astrocyte proliferation

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Factor Receptor Implications in Breast Cancer: Prospects for Their Molecular Transactivation in the Future and Obstacles for Target Therapy;Interdisciplinary Cancer Research;2024

2. Study on in vitro therapeutic impact of 17-ꞵ Estradiol on Glioblastoma cell lines;Research Journal of Biotechnology;2023-11-05

3. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment;Journal of Cancer Research and Clinical Oncology;2023-03-11

4. Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells;International Journal of Molecular Sciences;2022-10-06

5. Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers;Cancers;2021-07-24